Michelle Paternoster Foundation For Sarcoma Research
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2016 | 108,754 | 70,055 | 38,699 | 7.5 | — |
| 2017 | 67,917 | 62,050 | 5,867 | 9.6 | — |
| 2018 | 105,332 | 82,608 | 22,724 | 10.5 | — |
| 2019 | 96,173 | 77,600 | 18,573 | 14.1 | — |
| 2020 | 72,978 | 91,500 | −18,522 | 9.5 | — |
| 2021 | 95,267 | 60,000 | 35,267 | 21.5 | — |
| 2022 | 92,271 | 125,700 | −33,429 | 7.1 | 0% |
| 2023 | 166,895 | 119,371 | 47,524 | 12.2 | 0% |
In its most recent public year (2023), this organization brought in $47,524 more than it spent. Its reserves stood at about 12.2 months of spending, up from 7.5 in 2016. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Michelle Paternoster Foundation For Sarcoma Research's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works